Anesthesia effect of remimazolam assisted brachial plexus block anesthesia in upper limb surgery

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200065489

Enrollment

Unknown

Registered

2022-11-07

Start date

2022-11-10

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adjunctive sedation of brachial plexus block

Interventions

group of remizolam:remimazolam

group of dexmedetomidine:dexmedetomidine

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 18-65 years; 2. American Society of Anesthesiologists (ASA) Class I-II; 3. Unilateral upper limb surgery under brachial plexus block; 4, BMI 18-30 kg/m2; 5. Sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Have a history of mental illness or take psychotropic drugs; 2. Sinus bradycardia or atrioventricular block; 3. Pregnant or lactating women; 4. Contraindications of anesthetic drugs in this study; 5. Have sleep apnea syndrome; 6. Systolic blood pressure >= 180 mmHg or diastolic blood pressure >= 110 mmHg.

Design outcomes

Primary

Measure	Time frame
modified obsevers assessment of alertness/sedation scale, MOAA/S;bispectral index, BIS;	—

Secondary

Measure	Time frame
mean arterial pressure;peripheral oxygen saturation;heart rate;respiratory rating rate;	—

Countries

China

Contacts

Public ContactXie Wenqin

The First Hospital of Quanzhou City, Quanzhou, Fujian, China

xiewenqin9@126.com+86 13599269966

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026